Antiviral treatment study for children with chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This study looks at how well antiviral medicines work for children with long-term hepatitis B. It may help doctors find the best way to treat or stop treatment for kids who have had the virus for a while.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be at least 1 year old and under 13.
- Child must have had hepatitis B for over 6 months (based on blood tests).
- A parent or guardian must sign a consent form. If the child is 8 or older, they also need to agree in writing.
- For kids who have never been treated: no prior antiviral medicine.
- For kids already on treatment: must have been taking antiviral pills for at least 1 year, have a negative HBV DNA test, and no interferon in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests antiviral therapy in babies under 1 year old who have hepatitis B virus (HBV) but no other liver infections. The goal is to see if treatment can help control the virus and protect their liver.
This trial tests if peginterferon alfa-2b can help children with chronic hepatitis B achieve a functional cure. If your child has had hepatitis B for a while and still has the virus in their blood, this study might be an option.
This study looks at long-term outcomes in people with chronic hepatitis B who take antiviral medicines or receive interferon. It may help doctors understand which treatments work best over time and who is most likely to benefit.
This trial tests whether adding a short course of interferon to standard antiviral medicine (entecavir) helps younger children with chronic hepatitis B whose immune system has not yet started fighting the virus. It aims to see if this combination can lead to a functional cure.
This trial tests an experimental vaccine therapy to help control or possibly cure chronic hepatitis B. It is designed to see whether the treatment is safe and how well it affects the hepatitis B virus in adults.
This trial compares two treatments for young children (ages 3–6) with active chronic hepatitis B: entecavir alone versus entecavir plus a short course of pegylated interferon. The goal is to see if adding interferon helps control the infection better.
Hear when a new HBV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.